Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Decitabine + Oxaliplatin in Relapsed/Metastatic RCC
NCT04049344Phase 2Unknown
- Sponsor
- Zhejiang Cancer Hospital
- Start
- Aug 2019
- Primary completion
- Jun 2021
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of decitabine, oxaliplatin in renal cell carcinoma (RCC), sponsored by Zhejiang Cancer Hospital. Status: unknown.
02
Drugs
decitabineoxaliplatin
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT04049344.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04049344.